Ministry of Public Health Convenes Institutional Review Board (IRB) Meeting

rasooli_admin
Tue, Oct 28 2025 3:17 PM
MOPH

The Ministry of Public Health convened a meeting of the Institutional Review Board (IRB), chaired by Dr. Mohammad Hassan Ghiyasi, the Deputy Minister for Health Policy and Promotion.

The session brought together advisors to the deputy minister, several central directors, and representatives from relevant institutions. Discussions centered on the IRB’s ongoing activities, the appointment of new members, and the revision of existing operational procedures.

Dr. Ghiyasi stressed the importance of transparency in the board’s operations and highlighted the need for evidence-based decision-making grounded in scientific data and credible research. He emphasized that all health-related studies must align with national priorities and ethical standards to ensure a more efficient and coordinated research process.

According to ministry officials, the review of the IRB’s procedures will be undertaken by a designated committee comprising senior ministry leaders, technical experts, and respected religious scholars.

Latest news

Fri, Oct 16 2026 11:38 AM
Background image

Mawlawi Abdul Qadeer Nazir Appointed as Director of Procurement of the Ministry of Public Health

Qari Abdul Wali Siddiqi, Deputy Minister of Finance and Administration Affairs of the Ministry of Public Health, formally introduced Mawlawi Abdul Qadeer Nazir as the newly appointed. . .

Tue, Oct 13 2026 2:49 PM
Background image

Two Advanced X-Ray Machines Provided to Provincial Hospitals in Ghazni and Badghis

Equipped with advanced technology, the machines were procured to improve the quality of healthcare services, facilitate the accurate and timely diagnosis of diseases, and strengthen. . .

Tue, Oct 13 2026 2:12 PM
Background image

Afghanistan Food and Drug Authority (AFDA) Holds Administrative Meeting

The AFDA held an administrative meeting chaired by Mawlawi Hamdullah Zahid, Deputy Minister for Food and Drug Affairs, and attended by directors of the relevant pharmaceutical. . .

BACK TO NEWS